ACM
CLB icon

Archon Capital Management’s Core Laboratories CLB Stock Holding History

Archon Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-117,252
Closed -$1.88M – 48
2025
Q4 		$1.88M Buy
+117,252
New +$1.75M 1.07% 31
2017
Q4 		– Sell
-22,820
Closed -$2.25M – 19
2017
Q3 		$2.25M Hold
22,820
– – 1.21% 19
2017
Q2 		$2.31M Hold
22,820
– – 1.88% 19
2017
Q1 		$2.64M Sell
22,820
-4,250
-16% -$494K 3.75% 10
2016
Q4 		$3.25M Buy
27,070
+2,470
+10% +$273K 5.59% 9
2016
Q3 		$2.76M Sell
24,600
-10,300
-30% -$1.19M 7.04% 8
2016
Q2 		$4.32M Sell
34,900
-37,600
-52% -$4.54M 5.2% 7
2016
Q1 		$8.15M Sell
72,500
-4,200
-5% -$436K 8.08% 4
2015
Q4 		$8.34M Sell
76,700
-24,500
-24% -$2.8M 5.93% 5
2015
Q3 		$10.1M Buy
101,200
+34,100
+51% +$3.71M 8.88% 2
2015
Q2 		$7.65M Sell
67,100
-40,900
-38% -$4.96M 7.49% 6
2015
Q1 		$11.3M Buy
108,000
+52,000
+93% +$5.54M 9.88% 3
2014
Q4 		$6.74M Buy
+56,000
New +$7.36M 4.74% 9

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Archon Capital Management's CLB Position: Q1 2026 in Review

Archon Capital Management sold out of Core Laboratories (CLB) in Q1 2026, closing a stake of 117,252 shares — an estimated $1.88M sold.

Archon Capital Management first reported a position in CLB in Q4 2014 and held it in 13 quarters. The position peaked at $11.3M in Q1 2015. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Archon Capital Management reported no remaining Core Laboratories position as of Q1 2026 after selling out during the quarter.
  • Archon Capital Management sold 117,252 Core Laboratories shares in Q1 2026, an estimated $1.88M.
  • Archon Capital Management first reported a position in Core Laboratories in Q4 2014 and held it in 13 quarters.
  • Archon Capital Management's Core Laboratories position peaked at $11.3M in Q1 2015.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Archon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.